WebApr 10, 2024 · Doctors can now use enfortumab vedotin as a first-line treatment for metastatic bladder cancer in people who cannot receive cisplatin-based chemotherapy, the standard first-line treatment. About half of all patients with metastatic bladder cancer are not able to receive cisplatin-based chemotherapy. WebApr 11, 2024 · Packiam learned within the last week that his hospital had run low on cisplatin, a chemotherapy drug that is commonly used for bladder cancer and improves the likelihood that surgery will be...
Targeting HNRNPU to overcome cisplatin resistance in …
WebDec 9, 2024 · Answer: Cisplatin-based chemotherapy has conventionally been the first-line (1L) treatment for patients with locally advanced and metastatic urothelial cancer (mUC) of the bladder. This treatment has resulted in overall survival (OS) benefit, with median OS of 13 to 15 months and approximately 15% long-term responses. WebBackground: The purpose of the study was to evaluate the benefit of adjuvant chemotherapy (AC) versus surgery alone in patients with muscle-invasive bladder cancer (MIBC). … simple paintings.com
Bladder Cancer Medication - Medscape
WebFeb 7, 2024 · Cisplatin-based chemotherapy is the first-line treatment for most cancers, including bladder cancer, breast cancer, and colorectal cancer. Although this treatment … WebCisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy Bladder cancer (BC) is a disease arising from the malignant cells of the urinary bladder. Myeloid-derived suppressor cells (MDSCs) expand broadly and have strong immunosuppressive activities in the cancer … WebGEMCITABINE-CISPLATIN is used to treat: Biliary tract cancer. Bladder cancer. Cervical cancer. Malignant mesothelioma. Non-small cell lung cancer (NSCLC). Ovarian cancer. Pancreatic cancer. This combination may also be used with other drugs or treatments or to treat other types of cancer. More About GEMCITABINE-CISPLATIN simple paintings of flowers